Progress in Vaccination against Cancer - 2023 (PIVAC-23)
A special issue of Onco (ISSN 2673-7523).
Deadline for manuscript submissions: closed (15 April 2024) | Viewed by 3961
Special Issue Editors
Interests: cancer immunology; cancer immunotherapy; biomarkers; precision oncology; immune resistance; cancer vaccines; immune escape; immune checkpoint inhibitors
Special Issues, Collections and Topics in MDPI journals
Interests: Immune genes in tumor microenvironment; tumor antigen-specific T-cell receptor frequencies in tumor microenvironment; targeted therapies for cancer; biomarkers
Special Issues, Collections and Topics in MDPI journals
Interests: cancer biomarkers; regulation of adaptive antitumor immunity; immune resistance mechanisms; Immune-based therapies for cancer; cancer stem cells
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are delighted to invite you to the next PIVAC meeting, entitled “The 23rd International Conference on Progress in Vaccination Against Cancer” (PIVAC-23), which will be held from 28th to 30th September 2023 at the Saint Savas Cancer Hospital, 171 Alexandras avenue, Athens, Greece. PIVAC-23 aims to connect scientists working in translational and clinical cancer research for three days of presentations on the most recent advances in the following fields: (i) immunotherapies (cellular, immune checkpoint blockade, vaccines); (ii) innate immunity and tumor control; (iii) host–tumor interactions in the tumor microenvironment; (iv) in vitro and in vivo models for cancer immunotherapies; (v) combinational cancer therapy approaches; and (vi) prognostic and predictive biomarkers in tumors and immune cells.
The website of PIVAC 23 is https://scep.gr/en/events/event/pivac2023/
You are cordially invited to submit your unpublished original work attending to recent advances in all aspects of computational methods related to cancer research for the following topics:
- cancer biomarkers for prognosis and prediction
- understanding TCR specificity and cross-reactivity for predicting epitope immunogenicity
- the tumor microenvironment and regulation of antitumor immunity
- immunotherapies and immune resistance
- cancer immunotherapies
Dr. Constantin N. Baxevanis
Dr. Sotirios P. Fortis
Dr. Maria Goulielmaki
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Onco is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer immunotherapy
- cancer vaccines
- immune resistance
- tumor microenvironment
- biomarkers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.